%0 Journal Article
%T Enterolactone modulates the ERK/NF-¦ÊB/Snail signaling pathway in triple-negative breast cancer cell line MDA-MB-231 to revert the TGF-¦Â-induced epithelial¨Cmesenchymal transition
%A Aniket V. Mali
%A Asavari A. Joshi
%A Mahabaleshwar V. Hegde
%A Shivajirao S. Kadam
%J Archive of "Cancer Biology & Medicine".
%D 2018
%R 10.20892/j.issn.2095-3941.2018.0012
%X Triple-negative breast cancer (TNBC) is highly metastatic, and there is an urgent unmet need to develop novel therapeutic strategies leading to the new drug discoveries against metastasis. The transforming growth factor-¦Â (TGF-¦Â) is known to promote the invasive and migratory potential of breast cancer cells through induction of epithelial¨Cmesenchymal transition (EMT) via the ERK/NF-¦ÊB/Snail signaling pathway, leading to breast cancer metastasis. Targeting this pathway to revert the EMT would be an attractive, novel therapeutic strategy to halt breast cancer metastasis
%K Enterolactone
%K breast cancer metastasis
%K EMT
%K invasion
%K migration
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994556/